Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis.
Elevated moral condemnation of third-party violations in multiple sclerosis patients.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report.
Place of perineal electrophysiologic testing in multiple sclerosis patients.
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
The Immune Pathogenesis of Multiple Sclerosis.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.
Stem cells in neurology - current perspectives.
Pain acts through fatigue to affect participation in individuals with multiple sclerosis.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Acute disseminated encephalomyelitis presenting as pyrexia of unknown origin.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
The Effect of a Creative Art Program on Self-Esteem, Hope, Perceived Social Support, and Self-Efficacy in Individuals With Multiple Sclerosis: A Pilot Study.
Acute Disseminated Encephalomyelitis in a Child Following Plasmodium vivax Malaria.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?
Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: A pilot study.
Sphingolipids: important players in multiple sclerosis.
Mode of action and clinical studies with alemtuzumab.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Pages
« first
‹ previous
…
335
336
337
338
339
340
341
342
343
…
next ›
last »